Because of current federal restrictions on medical marijuana research, it's still too soon to tell whether or not cannabis is be useful in the treatment of neurological disorders such as Parkinson's disease, epilepsy, and multiple sclerosis, according to the American Academy of Neurology (AAN). That being said, AAN recognizes the potential of medical cannabis in the treatment of such brain disorders, acknowledging its potential to reduce spasms, decrease pain, and control urinary incontinence in those suffering from MS.
The AAN supports the rescheduling of medical marijuana so that there is more freedom surrounding clinical research of the substance. Through further research, AAN hopes to discover learn about the harms or benefits of THC, the necessity of consistent dosing, whether or not research conducted overseas is applicable to treatments in the United States, and the effects of marijuana on the developing brain of young patients. Until then, they believe there is not sufficient data confirming the efficacy of cannabis as a treatment for brain disorders.
This information has been provided by Web MD and approved by our Chief Medical Officer.